RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode
Clinical trial NCT03870776 · COMPLETED
Trial details
- NCT number
- NCT03870776
- Sponsor
- Mapreg
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2024-11-07
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.